Lactulose for Cancer
((BLOOM) Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of this study is to see if lactulose can improve the effectiveness of immunotherapy in patients with advanced cancer.
Who Is on the Research Team?
Daniel Olson
Principal Investigator
University of Chicago
Are You a Good Fit for This Trial?
Inclusion Criteria
Exclusion Criteria
What Are the Treatments Tested in This Trial?
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
o Patients with melanoma receiving routine immunotherapy will be enrolled to receive lactulose (10 mg daily).
Patients with solid tumor cancers receiving routine immunotherapy will be enrolled to receive lactulose (10 mg daily).
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.